Citius Oncology Inc.

NASDAQ: CTOR · Real-Time Price · USD
1.61
-0.09 (-5.29%)
At close: Aug 20, 2025, 3:59 PM
1.61
0.00%
After-hours: Aug 20, 2025, 04:20 PM EDT

Citius Oncology Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022
Cash & Equivalents
112.00 26.52K 289.18K
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a
Receivables
n/a n/a n/a
Inventory
8.27M n/a n/a
Other Current Assets
n/a n/a n/a
Total Current Assets
10.97M 7.73M 2.69M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
73.4M 40M 40M
Total Long-Term Assets
73.4M 40M 40M
Total Assets
84.37M 47.73M 42.69M
Account Payables
3.71M 1.29M 92.31K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a n/a n/a
Other Current Liabilities
-588.8K n/a n/a
Total Current Liabilities
32.7M 21.05M 5.85M
Long-Term Debt
3.8M n/a n/a
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
5.53M 1.15M 576K
Total Liabilities
38.23M 22.2M 6.42M
Total Debt
3.8M n/a n/a
Common Stock
7.16K 167.00 242.00
Retained Earnings
-39.28M -18.13M -5.43M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
46.14M 25.54M 36.27M
Total Investments
n/a 70.63M 67.81M